This book provides a strategic framework for employers transitioning to self-funded healthcare plans, addressing one of the most significant and unpredictable cost drivers: specialty medications.
It introduces a practical, compliant model that integrates the federal 340B Drug Pricing Program with modern healthcare infrastructure, enabling organizations to reduce drug costs by 20–30% while maintaining quality care.
Combining legislative analysis, real-world implementation strategy, and economic modeling, the book equips employers, advisors, and healthcare stakeholders with the tools needed to move from reactive cost management to proactive cost control.

Reviews
There are no reviews yet.